OXiGENE, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (32)

View All

Latest Posts

About This Stock More About This Stock
Is OxiGene The Cheapest Biotech On The Nasdaq?
Article By: Small Cap Gems
Tuesday, March 31, 2015 11:40 AM EDT
OxiGene, a small and virtually unknown biotech stock on the Nasdaq, boasts an impressive pipeline, yet the stock now trades at exactly cash level after a major sell-off. With multiple near-term catalysts in sight, I think shares could rebound hard.
In this article: OXGN
Read
OXiGENE: First Patient Enrolled In Phase 1b/2 Study Of Fosbretabulin
Article By: Trevor Lowenthal
Wednesday, October 8, 2014 12:04 PM EDT
OXiGENE announces that the first patient has been enrolled in the Phase 1b/2 study of fosbretabulin in combination with Votrient(TM) (pazopanib) in patients with recurrent ovarian cancer.
In this article: OXGN
Read
All Posts

Latest Tweets for $OXGN

No tweets yet!

PARTNER HEADLINES

$OXGN

Comments Status Updates
Is OxiGene The Cheapest Biotech On The Nasdaq?
Dick Kaplan • 4/1/2015 2:26:30 AM

$OXGN looks very promising, thanks.

1 to 1 of 1 comments